← Back to Search

Virtual Reality for Pain and Anxiety During Medical Procedures

N/A
Waitlist Available
Led By Andy M Chang, MD
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be administered to participants approximately 20 minutes before the start of the vcug.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if virtual reality can help reduce pain and anxiety for children during a medical procedure.

Who is the study for?
This trial is for English or Spanish speaking children aged 5-21 undergoing a bladder diagnostic scan at CHLA, without cognitive/neurological disorders, not on pain/anxiety meds, and with normal development. Children with seizures, psychiatric disorders, sensory deficits, motion sickness or regular catheterization are excluded.
What is being tested?
The study tests if VR using Oculus Go can reduce pain and anxiety in kids during bladder scans (VCUG) at CHLA. It's a non-drug approach to help cope with the discomfort of catheterization required during these urological exams.
What are the potential side effects?
Potential side effects from using VR may include motion sickness in some children. However, those prone to motion sickness are not included in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be administered to participants approximately 20 minutes before the start of the vcug, and within 15 minutes following the end of the vcug.
This trial's timeline: 3 weeks for screening, Varies for treatment, and will be administered to participants approximately 20 minutes before the start of the vcug, and within 15 minutes following the end of the vcug. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pain during VCUG - Pain Visual Analog Scale
Secondary study objectives
Baseline Anxiety before VCUG - Anxiety Sensitivity Index
Change in Anxiety during VCUG - Facial Affective Scale
Change in Anxiety during VCUG - Procedural Anxiety Visual Analog Scale
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VR RandomizationExperimental Treatment1 Intervention
Patients will receive virtual reality in addition to standard of care.
Group II: Standard of Care (No VR) RandomizationActive Control1 Intervention
Patients will receive standard of care during catheterization, which includes caregiver presence in the room and Child Life Specialists in the room, if desired, and does not include virtual reality.

Find a Location

Who is running the clinical trial?

National Association of Theater OwnersUNKNOWN
Children's Hospital Los AngelesLead Sponsor
249 Previous Clinical Trials
5,074,264 Total Patients Enrolled
Andy M Chang, MDPrincipal InvestigatorChildren's Hospital Los Angeles

Media Library

VR Randomization Clinical Trial Eligibility Overview. Trial Name: NCT04251988 — N/A
Urological Diseases Research Study Groups: Standard of Care (No VR) Randomization, VR Randomization
Urological Diseases Clinical Trial 2023: VR Randomization Highlights & Side Effects. Trial Name: NCT04251988 — N/A
VR Randomization 2023 Treatment Timeline for Medical Study. Trial Name: NCT04251988 — N/A
~70 spots leftby Dec 2025